Lixisenatide Subcutaneous ve Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)
Lixisenatide Subcutaneous ve Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) etkileşiminin ve ortak uygulama olasılığının belirlenmesi.
Seçilen ilaçlar arasında etkileşim bulunamadı veya birlikte uygulamanın etkileri yeterince araştırılmamıştır, etkileşimlerini belirlemek için zaman ve biriken istatistikler gereklidir. İlaçların birlikte uygulanması konusunda bir doktora danışılması gerekir.
Jenerik adı: lixisenatide
Marka adı: Adlyxin
Eşdeğer ilaçlar: Lixisenatide
Jenerik adı: human papillomavirus vaccine
Marka adı: Gardasil 9, Cervarix
Eşdeğer ilaçlar: Human papillomavirus (HPV) vaccine, 9-valent, Papillomavirus (9-Valent) Vaccine (Human, Recombinant)
İlaç uyumluluğu ve etkileşimlerinin kontrolü sürecinde, Drugs.com, Rxlist.com, Webmd.com ve Medscape.com rehberleri kullanılmıştır.
- Lixisenatide Subcutaneous-Para-Time S.R.
- Lixisenatide Subcutaneous-Paracetamol
- Lixisenatide Subcutaneous-Paraflex
- Lixisenatide Subcutaneous-Parafon DSC
- Lixisenatide Subcutaneous-Parafon Forte DSC
- Lixisenatide Subcutaneous-Paraldehyde Oral, Injection, Rectal
- Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)-Lixtraxen Injection
- Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)-LMD
- Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)-LMD Injection
- Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)-LMX 4 Topical application
- Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)-LMX 5
- Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)-LMX 5 Topical application
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant) 
Lixisenatide Subcutaneous - Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)